Primary Site >> Pancreatic Cancer

Gene >> NFKBIA

  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
PMID: 9918209
Ref: Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
PMID: 10210643
Ref: Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA.
PMID: 10467400
Ref: Evidence that de novo protein synthesis is dispensable for anti-apoptotic effects of NF-kappaB.
PMID: 10822373
Ref: Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma.
PMID: 11096450
Ref: Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.
PMID: 11314019
Ref: Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression.
PMID: 11368781
Ref: PI-3' kinase and NF-kappaB cross-signaling in human pancreatic cancer cells.
PMID: 12086898
Ref: Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines.
PMID: 11830551
Ref: Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death.
PMID: 12219002
Ref: [Expression of NF-kappa B in human bladder cancer and its clinical significance].
PMID: 12452071
Ref: Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis.
PMID: 12618762
Ref: Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.
PMID: 12761494
Ref: Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
PMID: 12767057
Ref: Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkappaBalpha super-repressor.
PMID: 12824895
Ref: NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells.
PMID: 14639600
Ref: Increased expression of NF-kappa B subunits in human pancreatic cancer cells.
PMID: 15093710
Ref: N-Acetyl-L-cysteine enhances apoptosis through inhibition of nuclear factor-kappaB in hypoxic murine embryonic fibroblasts.
PMID: 15375156
Ref: Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
PMID: 15827332
Ref: GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability.
PMID: 16353139
Ref: Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
PMID: 16985059
Ref: Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.
PMID: 17050666
Ref: Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors.
PMID: 17200110
Ref: Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
PMID: 17410536
Ref: Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-{kappa}B.
PMID: 17671195
Ref: IkappaBalpha kinase inhibitor IKI-1 conferred tumor necrosis factor alpha sensitivity to pancreatic cancer cells and a xenograft tumor model.
PMID: 19010928
Ref: Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
PMID: 19050262
Ref: N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression.
PMID: 19491262
Ref: Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.
PMID: 19670328
Ref: Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway.
PMID: 19722233
Ref: TGF-beta downregulates PTEN via activation of NF-kappaB in pancreatic cancer cells.
PMID: 19940030
Ref: miR-146a suppresses invasion of pancreatic cancer cells.
PMID: 20124483
Ref: NF-kappaB promotes epithelial-mesenchymal transition, migration and invasion of pancreatic carcinoma cells.
PMID: 20350779
Ref: Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathway.
PMID: 20367887
Ref: Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells.
PMID: 20416281
Ref: Gemcitabine combined with gum mastic causes potent growth inhibition and apoptosis of pancreatic cancer cells.
PMID: 20523344
Ref: Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells.
PMID: 20686216
Ref: Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model.
PMID: 20811662
Ref: Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer.
PMID: 20959520
Ref: Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells.
PMID: 25242818
Ref: Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8).
PMID: 20717964
Ref: PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKalpha and sustained activation of the NF-kappaB pathway.
PMID: 21376459
Ref: Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
PMID: 21484229
Ref: Requirement of nuclear factor kappaB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis.
PMID: 22241962
Ref: PP2A inhibitors induce apoptosis in pancreatic cancer cell line PANC-1 through persistent phosphorylation of IKKalpha and sustained activation of the NF-kappaB pathway.
PMID: 26904954
Ref: Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.
PMID: 22618517
Ref: CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor kappaB: implications for bidirectional tumor-stromal interactions.
PMID: 22995914
Ref: Concurrent chemotherapy inhibits herpes simplex virus-1 replication and oncolysis.
PMID: 23348635
Ref: Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-kappaB activation for pancreatic cancer.
PMID: 23348695
Ref: Targeting the NF-kappaB and mTOR pathways with a quinoxaline urea analog that inhibits IKKbeta for pancreas cancer therapy.
PMID: 23444213
Ref: An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB- and hypoxia-inducible factor 1alpha-mediated up-regulation of CXCR4.
PMID: 23740244
Ref: Digitoflavone inhibits IkappaBalpha kinase and enhances apoptosis induced by TNFalpha through downregulation of expression of nuclear factor kappaB-regulated gene products in human pancreatic cancer cells.
PMID: 24146961
Ref: MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha.
PMID: 24504166
Ref: S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer.
PMID: 24637492
Ref: Differential activity of GSK-3 isoforms regulates NF-kappaB and TRAIL- or TNFalpha induced apoptosis in pancreatic cancer cells.
PMID: 24675460
Ref: Apoptosis induced by microwave radiation in pancreatic cancer JF305 cells.
PMID: 24708215
Ref: p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway.
PMID: 25238288
Ref: Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
PMID: 26209568
Ref: Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-kappaB activation.
PMID: 26445000
Ref: RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.
PMID: 27181206
Ref: Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
PMID: 27322737
Ref: A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.
PMID: 27401816
Ref: Negative control of TRAIL-R1 signaling by transforming growth factor beta1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
PMID: 27492861
Ref: Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Human Cancer Cells through Reactive Oxygen Species-Mediated NF-kappaB Activations.
PMID: 27791350
Ref: RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells.
PMID: 28234980
Ref: Sporamin induces apoptosis and inhibits NF-kappaB activation in human pancreatic cancer cells.
PMID: 28714369
Ref: Centrosomal protein 55 activates NF-kappaB signalling and promotes pancreatic cancer cells aggressiveness.
PMID: 28724890
Ref: SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer.
PMID: 29059173
Ref: Matrine inhibiting pancreatic cells epithelial-mesenchymal transition and invasion through ROS/NF-kappaB/MMPs pathway.
PMID: 29155301